Why Link-in-Bio Tools Keep Shutting Down (2026)

Four link-in-bio (or link-in-bio-adjacent) tools have shut down since January 2024. Koji went first. Bento.me followed in February 2026. Tap Bio announced its October 2026 shutdown in April. kit.co, the Patreon-owned product showcase, joined the list in May. Each closure pushed creators into a scramble to migrate their links, often with less than a month of notice.

So why do link-in-bio tools keep shutting down? The short answer: link-in-bio is a brutal business. Revenue per user is low, the core feature is easy to clone, and most companies in the space are venture-backed with capital that eventually runs out. Picking a tool that will stick around means evaluating five things: revenue model, age, team continuity, hosting setup, and jurisdiction. Tools that score well on all five (independent, profitable, 5+ years old, founder-led, geographically diversified) are statistically safer bets than VC-backed indie launches.

This guide walks through what shut down, why the pattern keeps repeating, and how to evaluate the next bio link tool you're about to commit to.

The Shutdown Cluster: Four Tools in 26 Months

Each shutdown tells the same story in different details.

Koji disappeared in January 2024. Koji was a creator monetization platform with a bio page layer. It raised funding, scaled the team, then quietly wound down. The shutdown timeline was unclear; users woke up to broken pages and a sparse exit notice. Koji still shows up in some tool comparisons, often as a placeholder that nobody has bothered to remove.

Bento.me announced its shutdown in late January 2026 and went dark on February 13, 2026. Roughly two weeks of notice for users to export and migrate. Bento positioned itself as a personal landing page with built-in bio link features, and pulled in a creator-heavy user base before pivoting away from the surface it had built. Our Bento.me alternatives roundup covered the post-shutdown migration paths.

Tap Bio announced in April 2026 that it would close on October 31, 2026. About six months of runway, the longest of the four. Tap Bio's card-based interface attracted a slower-growing user base, mostly photographers and visual creators. The closure notice is the warmest of the four, but the outcome is the same: pages go dark, links break, and the audience that found you through that URL gets a 404. See our Tap Bio shutdown migration guide if you're affected.

kit.co joined the list in May 2026. kit.co was a Patreon product showcase tool that had been quietly deprioritized for over a year. Patreon's announcement was short: the feature would no longer fit the company's roadmap. Two weeks of notice. A handful of dedicated users routed to Linktree, Beacons, or self-hosted setups.

These shutdowns sit on top of older ones. Linkfire's bio link product was shelved years ago. Various indie experiments lasted less than 18 months and never made it onto anyone's comparison list. The pattern isn't four shutdowns in 26 months. It's four shutdowns this cycle.

Why Link-in-Bio Tools Keep Failing

The pattern is consistent enough that you can predict the next one. Five forces drive it.

1. Low Average Revenue Per User

The link-in-bio market has trained users to expect a free tier and pay-as-you-go pricing in the $5 to $15 per month range. That is brutal economics for a venture-backed company. Most VC funds target investments that can reach $50+ ARPU within a few years; a $9 product cannot get there without either a major price hike or a heavy enterprise pivot. Bento.me, Tap Bio, and Koji all sat in the low-ARPU band. None of them had a clear path to the enterprise revenue VCs want to see.

2. A Single-Feature Business Is Easy to Clone

"We let you put links in your bio" is a half-day build for any competent engineer. The moat has to come from somewhere else. Linktree built distribution as the moat. Beacons leaned into AI tooling. Smaller players did not have a comparable advantage, and once the category matured, distinguishing yourself on the core feature became impossible.

3. The Capital Squeeze of 2022 to 2024

Venture funding contracted sharply during that window, and creator-economy startups were among the first to lose access to follow-on rounds. Tools that needed Series B funding to extend runway did not get it. Some pivoted into adjacent products that did not pan out. Others wound down.

4. Founder Fatigue

Many link-in-bio tools were built by solo founders or two-person teams. Five years of running a product where users pay $5 a month and expect enterprise support is exhausting. When the founder loses motivation and the funding isn't there to hire someone to take over, the product fades. Tap Bio fits this story closely.

5. Acquisition Divestiture

When a larger company owns a bio link product as a side feature, that feature becomes vulnerable when the parent shifts priorities. kit.co is the cleanest example: a Patreon product, killed when Patreon refocused. Linkfire's bio link tool followed a similar arc.

These forces are not going away. Any tool that depends on cheap subscriptions plus VC capital plus a single feature is exposed to all five. The casualties of the next cycle are probably already in the comparison lists you are reading.

How to Tell If a Link-in-Bio Tool Is Built to Last

Five durability heuristics, in rough order of importance.

Revenue Model

Is the company profitable, VC-funded, or bootstrapped? Profitable plus bootstrapped is the highest-durability combination because the company does not need the next funding round to keep operating. VC-funded with no clear path to profitability is the highest risk: the company is on a runway clock, and when the clock runs out, the product runs out with it.

Age

Tools that have operated for 5+ years have survived the founder-fatigue, capital-squeeze, and feature-cloning waves at least once. Linkero has been running since 2019. Lnk.Bio launched in 2016. Linktree launched in 2016. Beacons launched in 2020. The casualties of this cycle (Bento.me, Tap Bio, kit.co) were younger or in active transition. Age alone does not guarantee survival, but it correlates strongly with it.

Team Continuity

Is the founder still active? Is the team larger than one person but smaller than fifty? A 50-person VC-funded team can collapse fast: no runway, layoffs, wind-down. A 1-to-3-person profitable team can keep operating for decades. Counter-intuitively, smaller can be safer when the small team is genuinely sustainable.

Hosting Setup

Self-hosted alternatives like LittleLink and LinkStack shift the durability question from "will the company survive" to "will you keep paying for a VPS and patching the security holes." That is a tradeoff, not a free lunch. If you are technical enough to maintain a server, self-hosting solves the shutdown risk entirely. If you are not, sticking with a managed tool that scores well on the other four heuristics is more durable in practice. Our self-hosted vs managed comparison covers the full picture.

Jurisdiction

US-based tools face one set of corporate dissolution dynamics: Delaware C-corp wind-down rules, US bankruptcy law, dollar-denominated capital pressure. EU-based tools face a different set: SL or GmbH structures, EU regulatory environments, euro-denominated capital. Neither is automatically safer, but geographic diversity matters at the portfolio level. If most of your tools are US-VC-funded and one shock hits that side of the Atlantic, you are more exposed than you should be.

Pricing Model Bonus

Lifetime or one-time-payment plans (Lnk.Bio's $9.99 Mini lifetime is a clean example) signal a company comfortable with steady-state revenue. Aggressive subscription-only models with explicit growth targets signal the opposite: an exit chase. Neither is automatically better, but the pricing signal is real.

What Happens When Your Bio Tool Shuts Down

It is worth knowing the actual cost so you can value durability properly.

• Your bio link breaks. Usually with a 30-to-90 day grace period, then a 404 or a redirect to the parent company.
• Your custom domain may or may not survive. Some tools support exporting your custom domain configuration; others lose the DNS knowledge entirely.
• Analytics history is usually lost. Even tools that offer "export" often only export current links, not the click history that informed which links worked.
• Email capture and lead data export varies. Some tools give you a clean CSV; some make you scrape the dashboard before shutdown; some lose it entirely.
• In-platform discovery dies. If your audience reached you through the tool's directory or discovery feed, those entry points disappear.
• Migration cost. Realistic numbers from the recent shutdowns: 2 to 8 hours per bio page to migrate (links, design, custom domain reconfig). For agencies managing dozens of client pages, that scales fast.

Add to that the soft cost: every time a creator updates a bio link, the platform they have recommended to peers, students, or clients shapes their reputation. Recommending a tool that shuts down 18 months later is a credibility hit.

The Durable-Tool Checklist

Print this. Use it before you commit to the next bio link tool.

• Founded 5+ years ago
• Profitable or self-funded, not actively burning VC cash
• Founder still active, team larger than one person
• Clear monetization model (subscription or lifetime, not pure growth-at-all-costs)
• Data export available in under 5 minutes (links, analytics, contacts)
• Custom domain support, so a shutdown does not kill your URL
• No platform-specific lock-in (your audience reaches you via your URL, not the tool's discovery feed)

A tool that scores 5 out of 7 is reasonable. 6 or 7 is durable. Anything below 4 is a meaningful shutdown risk over a 3-year horizon.

Where Linkero Sits on the Checklist

For transparency, here is how Linkero scores against the same heuristics.

That is not a vanity score. It is a deliberate set of choices: stay independent, stay profitable, stay small enough that the founder is still the person answering support emails. The tradeoff is that you will not see Linkero on a Times Square billboard. The benefit is that you also will not see Linkero on the 2027 shutdown list.

If you want the side-by-side against the largest competitor, our Linktree vs Linkero breakdown covers features, pricing, and positioning. For the full pricing detail, see the Linkero pricing page.

Signals That Your Current Tool Might Be Next

Five quiet indicators tend to precede shutdowns by three to six months. None of them is a guarantee, but three or more showing up together is a strong tell.

1. Unexplained pricing changes. A 30-to-70 percent price hike without a matching feature expansion usually signals investor pressure or a desperate path to profitability.
2. Team page shrinkage. Compare an archived version of the about page with the current one. A team that has gone from 25 people to 8 is in trouble.
3. Blog stagnation. If the company blog has not published in three months, somebody internally is making cuts.
4. Changelog stagnation. Feature work has slowed or stopped. Bug fixes only. No new integrations, no roadmap posts.
5. Founder silence. The founder has stopped posting on social, stopped doing podcast interviews, stopped showing up at events.

All four of the recent shutdowns (Bento.me, Tap Bio, kit.co, and Koji before them) showed at least three of those signs for several months pre-announcement.

FAQ

Is Linktree going to shut down?

Linktree is the largest player by user count (70M+ in 2026) and is the most likely to survive of the major bio link tools. That said, Linktree raised prices roughly 67 percent in November 2025 (per Lnk.Bio's tracked pricing comparisons), which signals investor pressure even at the largest tier. The July 5, 2026 Privacy Notice and Terms update also adds an OpenAI/ChatGPT data-sharing clause and a new "Generative AI" section to the TOS, both of which change what creators are agreeing to long-term. Survival is not the same as great pricing or great product. For a deeper trust-and-stability view, see Is Linktree Safe.

Which link-in-bio tools have shut down recently?

Koji (January 2024), Bento.me (February 2026), Tap Bio (announced April 2026, dark October 31, 2026), and kit.co (May 2026, Patreon-owned). Older shutdowns include Linkfire's bio link product and various indie launches that did not make it past 18 months.

How do I know if my link-in-bio tool will shut down?

There is no perfect signal, but five quiet indicators tend to precede shutdowns by three to six months: pricing changes (unexplained hikes), team page shrinkage, blog stagnation, changelog stagnation, and founder silence on social. All four recent shutdowns showed at least three of those signs for several months pre-announcement.

How long has Linkero been around?

Linkero is independent, founder-led, profitable, based in Spain (EU jurisdiction), and has been operating since 2019.

What is the most reliable link-in-bio tool?

By durability heuristics (age, profitability, team continuity, jurisdiction), three names score consistently well: Lnk.Bio (2016, lifetime-payment), Linktree (2016, scale but pricing risk), and Linkero (2019, independent and EU-based). Each has different tradeoffs on features and pricing, so the right pick depends on what you are optimizing for beyond durability. Our best link-in-bio tools roundup goes deeper.

Will Linkero shut down?

No tool can promise indefinite uptime, but Linkero is structured to minimize the standard shutdown risks: independent ownership, profitable operation, founder-led team, EU-based, no VC runway clock. The most common failure modes (VC squeeze, founder exit, acquisition divestiture) do not apply.

What happens to my custom domain if a bio tool shuts down?

Your domain itself is yours (you own the registration). What you lose is the DNS configuration pointing the domain at the bio tool's servers, plus any tool-specific subdomain setups. If you have a backup of your link list and your domain registrar credentials, repointing to a new tool takes about an hour. If you do not, expect a few hours of reconstruction work plus some downtime.

Picking a Tool You Will Not Have to Migrate Again

The bio link is a multi-year commitment. Your custom URL ends up on every social profile, email signature, business card, and printed flyer you have made. Replacing it means updating every one of those surfaces, then hoping your audience follows. The cost of getting the durability question wrong compounds.

Don't optimize purely for features. Optimize for the company behind the features. Independent, profitable, founder-led, geographically diversified tools score better on durability than VC-backed growth-at-all-costs companies, even when the second group has a flashier feature list.